Evaluation of Tumor Resection and Reconstruction With Prosthetic Implants

NCT07337018 | Not Yet Recruiting

• 1 other identifier: 7224
• Study Type: observational
• Target: 100
• Locations: 0 countries
• Sites: N/A

Brief Summary

Bone can be the site of primary malignant tumors or, more commonly, secondary lesions. The most frequent primary tumors are osteosarcoma, chondrosarcoma, and Ewing sarcoma, whereas the malignancies that most commonly metastasize to bone include breast, prostate, lung, kidney, and thyroid cancers. For the treatment of these conditions-and, in some cases, for locally aggressive benign diseases-a surgical approach is often required, which may result in substantial bone loss. Most commercially available prostheses commonly used in orthopedic surgery are not always suitable, either because of the anatomical location of the procedure or the type of resection planned, and thus the extent of the bone defect to be reconstructed. Therefore, specific prosthetic implants designed for oncologic surgery are required. For this reason, modular prostheses have been developed, allowing reconstruction of bone defects of varying sizes across different anatomical districts. In recent years, the development and use of 3D-printing technology for producing custom-made prostheses has also increased, with the aim of reconstructing bone defects in areas that are difficult to treat and achieving an accurate reproduction of the patient's anatomy. This technology enables reconstruction in a wide range of skeletal sites. Additionally, it allows for preoperative planning on printed anatomical models and opens the possibility of integrating materials with adjuvant-related properties into the prosthetic design, such as photothermal therapy or antimicrobial features. Although numerous studies on this topic are available in the literature, they frequently involve small patient cohorts. There is therefore a need to expand case series with longer follow-ups to better assess the reliability and effectiveness of these treatment strategies in the development of reconstructive orthopedic oncologic surgery.

Conditions

Bone Tumor

Outcome Measures

Primary Outcomes (5)

• Karnofsky Performance Status

  Postoperative quality of life and functional status assessed using the Karnofsky Performance Status score.

  From enrollment for at least one year

• Musculoskeletal Tumor Society (MSTS) Score

  Postoperative functional outcome assessed using the Musculoskeletal Tumor Society (MSTS) scoring system.

  At final follow-up

• Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) Score

  Upper-limb functional outcome assessed using the QuickDASH questionnaire in patients with upper extremity involvement

  From enrollment for at least one year

• Oxford Knee Score

  Knee functional outcome assessed using the Oxford Knee Score in patients with knee involvement

  From enrollment for at least one year

• Harris Hip Score

  Hip functional outcome assessed using the Harris Hip Score in patients with hip involvement.

  From enrollment for at least one year

Secondary Outcomes (1)

• Incidence of postoperative complications

  From enrollment for at least one year

Eligibility Criteria

• Age: 30 Years - 70 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients with primary or secondary bone tumors treated at the Policlinico A. Gemelli

You may qualify if:

• Age between 30 and 70 years;
• Diagnosis of primary malignant or locally aggressive benign bone tumors, or secondary bone lesions with a primary diagnosis of breast, lung, prostate, kidney, or thyroid cancer;
• Extensive bone loss precluding the use of currently available prostheses or standard surgical techniques;
• Use of modular or custom-made prostheses produced with 3D-printing technology; minimum follow-up of 12 months;
• (For patients in the retrospective phase) completion of evaluation questionnaires during outpatient follow-ups;
• Obtaining Informed Consent, except for deceased patients enrolled in the retrospective phase of the study.

You may not qualify if:

• Patients with disease spread to other bone segments;
• Age \<30 years or \>70 years;
• Patients who have undergone previous surgical procedures on the involved segment;
• Follow-up of less than 1 year;
• Incomplete clinical or radiological data sets;
• Inability to obtain Informed Consent, except for deceased patients enrolled in the retrospective phase of the study

Sponsors & Collaborators

• Fondazione Policlinico Universitario Agostino Gemelli IRCCS: lead

Related Publications (18)

• Sambri A, Zucchini R, Giannini C, Zamparini E, Viale P, Donati DM, De Paolis M. Silver-coated (PorAg(R)) endoprosthesis can be protective against reinfection in the treatment of tumor prostheses infection. Eur J Orthop Surg Traumatol. 2020 Dec;30(8):1345-1353. doi: 10.1007/s00590-020-02705-3. Epub 2020 May 24.

  PMID: 32449080 BACKGROUND

• Donati F, Di Giacomo G, D'Adamio S, Ziranu A, Careri S, Rosa M, Maccauro G. Silver-Coated Hip Megaprosthesis in Oncological Limb Savage Surgery. Biomed Res Int. 2016;2016:9079041. doi: 10.1155/2016/9079041. Epub 2016 Aug 23.

  PMID: 27642605 BACKGROUND

• Wang X, Liu Y, Zhang M, Zhai D, Wang Y, Zhuang H, Ma B, Qu Y, Yu X, Ma J, Ma H, Yao Q, Wu C. 3D Printing of Black Bioceramic Scaffolds with Micro/Nanostructure for Bone Tumor-Induced Tissue Therapy. Adv Healthc Mater. 2021 Nov;10(21):e2101181. doi: 10.1002/adhm.202101181. Epub 2021 Sep 15.

  PMID: 34523255 BACKGROUND

• Zhu C, He M, Sun D, Huang Y, Huang L, Du M, Wang J, Wang J, Li Z, Hu B, Song Y, Li Y, Feng G, Liu L, Zhang L. 3D-Printed Multifunctional Polyetheretherketone Bone Scaffold for Multimodal Treatment of Osteosarcoma and Osteomyelitis. ACS Appl Mater Interfaces. 2021 Oct 13;13(40):47327-47340. doi: 10.1021/acsami.1c10898. Epub 2021 Sep 29.

  PMID: 34587454 BACKGROUND

• Girolami M, Boriani S, Bandiera S, Barbanti-Brodano G, Ghermandi R, Terzi S, Tedesco G, Evangelisti G, Pipola V, Gasbarrini A. Biomimetic 3D-printed custom-made prosthesis for anterior column reconstruction in the thoracolumbar spine: a tailored option following en bloc resection for spinal tumors : Preliminary results on a case-series of 13 patients. Eur Spine J. 2018 Dec;27(12):3073-3083. doi: 10.1007/s00586-018-5708-8. Epub 2018 Jul 23.

  PMID: 30039254 BACKGROUND

• Liang H, Yang Y, Guo W, Yan L, Tang X, Li D, Qu H, Zang J, Du Z. Elbow hemiarthroplasty with a 3D-printed megaprosthesis for defects of the distal humerus or proximal ulna after tumour resection : a preliminary report. Bone Joint J. 2022 Jun;104-B(6):747-757. doi: 10.1302/0301-620X.104B6.BJJ-2021-1516.R1.

  PMID: 35638204 BACKGROUND

• Park JH, Jung HW, Jang WY. The usefulness of a three-dimensional printed segmental scapula prosthesis for recovering shoulder function in a patient with scapula chondrosarcoma: A case report. Medicine (Baltimore). 2021 Feb 26;100(8):e24817. doi: 10.1097/MD.0000000000024817.

  PMID: 33663101 BACKGROUND

• Beltrami G, Ristori G, Nucci AM, Galeotti A, Tamburini A, Scoccianti G, Campanacci D, Innocenti M, Capanna R. Custom-Made 3D-Printed Implants as Novel Approach to Reconstructive Surgery after Oncologic Resection in Pediatric Patients. J Clin Med. 2021 Mar 4;10(5):1056. doi: 10.3390/jcm10051056.

  PMID: 33806387 BACKGROUND

• Gursan O, Celtik M, Yanik B, Husemoglu RB, Havitcioglu H. Three-Dimensionally-Printed Joint-Preserving Prosthetic Reconstruction of Massive Bone Defects After Malignant Tumor Resection of the Proximal Tibia. Cureus. 2021 Mar 9;13(3):e13784. doi: 10.7759/cureus.13784.

  PMID: 33842159 BACKGROUND

• Yang QD, Mu MD, Tao X, Tang KL. Three-dimensional printed talar prosthesis with biological function for giant cell tumor of the talus: A case report and review of the literature. World J Clin Cases. 2021 May 6;9(13):3147-3156. doi: 10.12998/wjcc.v9.i13.3147.

  PMID: 33969102 BACKGROUND

• Xu L, Qin H, Cheng Z, Jiang WB, Tan J, Luo X, Huang W. 3D-printed personalised prostheses for bone defect repair and reconstruction following resection of metacarpal giant cell tumours. Ann Transl Med. 2021 Sep;9(18):1421. doi: 10.21037/atm-21-3400.

  PMID: 34733973 BACKGROUND

• Chen G, Yin Y, Chen C. Limb-salvage surgery using personalized 3D-printed porous tantalum prosthesis for distal radial osteosarcoma: A case report. Medicine (Baltimore). 2021 Nov 19;100(46):e27899. doi: 10.1097/MD.0000000000027899.

  PMID: 34797342 BACKGROUND

• Pu F, Liu J, Shi D, Huang X, Zhang J, Wang B, Wu Q, Zhang Z, Shao Z. Reconstruction With 3D-Printed Prostheses After Sacroiliac Joint Tumor Resection: A Retrospective Case-Control Study. Front Oncol. 2022 Jan 4;11:764938. doi: 10.3389/fonc.2021.764938. eCollection 2021.

  PMID: 35059310 BACKGROUND

• Wang S, Luo Y, Zhang Y, Wang Y, Zheng C, Tu C, Zhou Y. Case Report: Reconstruction of Medialis Malleolus (1/4 of the Ankle Joint) After Resection of Distal Tibia Tumor With an Uncemented Three-Dimensional-Printed Prosthesis. Front Surg. 2022 Mar 24;9:844334. doi: 10.3389/fsurg.2022.844334. eCollection 2022.

  PMID: 35402484 BACKGROUND

• Park JW, Kang HG. Application of 3-dimensional printing implants for bone tumors. Clin Exp Pediatr. 2022 Oct;65(10):476-482. doi: 10.3345/cep.2021.01326. Epub 2021 Dec 23.

  PMID: 34942688 BACKGROUND

• Zhang HR. Application and Development of Megaprostheses in Limb Salvage for Bone Tumors Around the Knee Joint. Cancer Control. 2022 Jan-Dec;29:10732748221099219. doi: 10.1177/10732748221099219.

  PMID: 35499495 BACKGROUND

• Thorkildsen J, Strom TA, Strom NJ, Sellevold S, Norum OJ. Megaprosthesis for Metastatic Bone Disease-A Comparative Analysis. Curr Oncol. 2022 May 10;29(5):3460-3471. doi: 10.3390/curroncol29050279.

  PMID: 35621669 BACKGROUND

• Denissen JJPM, Koenders N, van Hinte G, Groen F, van der Wees PJ, van der Geest ICM, Dierselhuis EF. Functional outcomes after reverse shoulder megaprosthesis following resection of malignant bone tumor in the proximal humerus: a systematic review and meta-analysis. JSES Int. 2023 Mar 31;7(4):592-600. doi: 10.1016/j.jseint.2023.02.018. eCollection 2023 Jul.

  PMID: 37426912 BACKGROUND

MeSH Terms

Conditions

Bone Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Bone Diseases; Musculoskeletal Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 11, 2025
• First Posted: January 13, 2026
• Study Start: January 1, 2026
• Primary Completion (Estimated): November 30, 2027
• Study Completion (Estimated): November 30, 2028
• Last Updated: January 13, 2026

Record last verified: 2025-12